advertisement
The CanSino approval comes on the heels of another new vaccine from Sinopharm Wuhan, which is also a double-dose vaccine that appears to be somewhat more effective than the up-to-now most commonly administered vaccine from Sinovac.
Besides being effective with only one dose, the CanSino vaccine is also China’s first viral vector vaccine. Compared with the Sinovac vaccine and other traditional “inactivated” vaccines, which use an inactivated version of the coronavirus to build immunity, the CanSino vaccine uses a viral vector – an adenovirus – to shuttle a specific protein inside the recipient’s cells, causing the immune system to produce antibodies that would effectively fight off COVID-19.
For the time being, Beijing residents are not able to choose the type of vaccine they receive. Only a single type of vaccine is available at each administration site in Beijing, and requests to transfer to a different site from the one you are assigned is not allowed.
READ: Mask After Vax? Yes! And Other Mask Questions Answered
Images: UNSPLASH, the Beijingers
advertisement